FNLC:NASDAQFirst Bancorp, Inc (ME) Analysis
Data as of 2026-05-29 - not real-time
$29.18
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
The stock is trading at $29.18, comfortably above its 20‑day ($28.65), 50‑day ($28.59) and 200‑day ($27.16) simple moving averages, and the MACD histogram is positive, indicating a bullish technical backdrop. RSI sits near 57, suggesting room for upside without being overbought, while a 30‑day volatility of roughly 22% and a beta under 0.8 point to moderate price swings but limited market‑wide risk.
Fundamentally, the company appears cheap: a trailing P/E of about 9 versus an industry average near 16.5, and a DCF‑derived fair value exceeding $70, signaling potential undervaluation. The dividend yield of just over 5% is supported by a payout ratio below 60%, and the balance sheet shows ample cash relative to debt. With no analyst coverage and market sentiment in “Extreme Greed” territory, short‑term price pressure is possible, but the underlying economics remain solid.
Fundamentally, the company appears cheap: a trailing P/E of about 9 versus an industry average near 16.5, and a DCF‑derived fair value exceeding $70, signaling potential undervaluation. The dividend yield of just over 5% is supported by a payout ratio below 60%, and the balance sheet shows ample cash relative to debt. With no analyst coverage and market sentiment in “Extreme Greed” territory, short‑term price pressure is possible, but the underlying economics remain solid.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish technical indicators
- Elevated market greed may trigger a pullback
- Strong dividend yield provides downside cushion
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation discount to DCF and peers
- Sustainable dividend supports total return
- Stable earnings growth and solid operating margins
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Consistent profitability and healthy cash flow generation
- Low beta and modest leverage reduce systemic risk
- Long‑term upside potential as regional banking fundamentals improve
Key Metrics & Analysis
Financial Health
Revenue Growth14.50%
Profit Margin37.83%
P/E Ratio9.0
ROE13.29%
ROA1.14%
P/B Ratio1.1
Op. Cash Flow$58.4M
Industry P/E16.6
Technical Analysis
TrendBullish
RSI56.9
Support$27.67
Resistance$29.99
MA 20$28.65
MA 50$28.59
MA 200$27.16
MACDBullish
VolumeStable
Fear & Greed Index93.57
Valuation
Fair Value$74.83
GradeUndervalued
TypeBlend
Dividend Yield5.09%
Risk Assessment
Beta0.73
Volatility22.57%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.